Evidence map›Paper›PMID 23114924›Full record

ArticleHuman pathology2013

Expression of hepatocyte epidermal growth factor receptor, FAS and glypican 3 in EpCAM-positive regenerative clusters of hepatocytes, cholangiocytes, and progenitor cells in human liver failure.

Alex Hattoum, Erin Rubin, Anne Orr, George K Michalopoulos

Abstract read
In one paragraph

Article in Human pathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. The Values and Perspectives of Organoids in the Field of Metabolic Syndrome.International journal of molecular sciences · 2023
    Review
  2. Article
  3. Article
  4. Liver regeneration: biological and pathological mechanisms and implications.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  5. Depletion of T cellsFrontiers in immunology · 2021
    Article
  6. Shedding light on the EpCAM: An overview.Journal of cellular physiology · 2019
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. The plastic liver: differentiated cells, stem cells, every cell?The Journal of clinical investigation · 2014
    Article
  17. Article
  18. The liver is a peculiar organ when it comes to stem cells.The American journal of pathology · 2014
    Article
  19. Immunohistochemical Analysis of the Stem Cell Marker LGR5 in Pediatric Liver Disease.Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alex HattoumDepartment of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Erin Rubin
Anne Orr
George K Michalopoulos
University of Pittsburgh · US

Funding

HGF IN LIVER REGENERATION, DIFFERENTIATION AND NEOPLASIAR01CA035373 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MICHALOPOULOS, GEORGE K · 1985 to 2011
$3.8M
HGF and Signaling Pathways in Hepatic Tissue AssemblyR01CA103958 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MICHALOPOULOS, GEORGE K · 2004 to 2014
$2.9M
NCI NIH HHS CA103958NCI NIH HHS CA35373NCI NIH HHS R01 CA035373NCI NIH HHS R01 CA103958
6 · The paper itself

Abstract

Liver regeneration under normal circumstances proceeds through proliferation of all cellular elements of the liver. Studies with rodent models have shown that when proliferation of hepatocytes is inhibited, progenitor cells arising from the biliary compartment transdifferentiate into "oval/progenitor" cells, which proceed to differentiate into hepatocytes. Recent studies have shown that the same pathways may operate in human liver failure. The growth factor receptors (HGF [hepatocyte growth factor] receptor) and epidermal growth factor receptor are key mitogenic receptors for both hepatocytes and progenitor cells. Our current study used the biliary and progenitor marker EpCAM (epithelial cell adhesion molecule) to detect "regenerative clusters" of mixed cholangiocyte-hepatocyte differentiation. We determined that expression of metabolic equivalent and epidermal growth factor receptor occurs in biliary cells, progenitor cells, and hepatocytes, whereas activation of metabolic equivalent and epidermal growth factor receptor is limited to regenerative cluster hepatocytes. These histologic events are associated with expression of apoptosis-inducing FAS and mitoinhibitory protein glypican 3. Cell proliferation was overall suppressed in regenerative clusters. Transdifferentiation of biliary and progenitor cells appears to be regulated by a complex interaction of signals promoting and arresting growth.

Indexed as

Antigens, NeoplasmCell Adhesion MoleculesCell DifferentiationCell ProliferationCell TransdifferentiationEpithelial Cell Adhesion MoleculeErbB Receptorsfas ReceptorGlypicansHepatocytesHumansLiver FailureProto-Oncogene Proteins c-metStem CellsAntigens, NeoplasmCell Adhesion MoleculesEGFR protein, humanEPCAM protein, humanEpithelial Cell Adhesion MoleculeErbB ReceptorsFAS protein, humanfas ReceptorGlypicansGPC3 protein, humanMET protein, humanProto-Oncogene Proteins c-met

Identifiers

PMID23114924
PMCPMC3635113
OpenAlexW1996102906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.